<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1898</number>
    <updateDate>2022-12-31T13:59:55Z</updateDate>
    <updateDateIncludingText>2022-12-31T13:59:55Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2021-05-27</introducedDate>
    <congress>117</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2021-05-27T17:09:45Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Affordable and Safe Prescription Drug Importation Act</title>
        <congress>117</congress>
        <number>2181</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2021-03-24</actionDate>
          <text>Referred to the Subcommittee on Health.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>End Taxpayer Subsidies for Drug Ads Act</title>
        <congress>117</congress>
        <number>141</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-01-28</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Affordable and Safe Prescription Drug Importation Act</title>
        <congress>117</congress>
        <number>920</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-03-23</actionDate>
          <text>Committee on Health, Education, Labor, and Pensions Subcommittee on Primary Health and Retirement Security. Hearings held.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Capping Prescription Costs Act of 2021</title>
        <congress>117</congress>
        <number>3339</number>
        <type>S</type>
        <latestAction>
          <actionDate>2021-12-08</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>No Tax Breaks for Drug Ads Act</title>
        <congress>117</congress>
        <number>6392</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2022-01-13</actionDate>
          <text>Referred to the House Committee on Ways and Means.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>PRICED Act</title>
        <congress>117</congress>
        <number>7828</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2022-05-18</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2021-05-27</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2021-05-27</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>S001203</bioguideId>
        <fullName>Sen. Smith, Tina [D-MN]</fullName>
        <firstName>Tina</firstName>
        <lastName>Smith</lastName>
        <party>D</party>
        <state>MN</state>
        <identifiers>
          <bioguideId>S001203</bioguideId>
        </identifiers>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>W000817</bioguideId>
        <fullName>Sen. Warren, Elizabeth [D-MA]</fullName>
        <firstName>Elizabeth</firstName>
        <lastName>Warren</lastName>
        <party>D</party>
        <state>MA</state>
        <identifiers>
          <bioguideId>W000817</bioguideId>
        </identifiers>
        <middleName>A.</middleName>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001277</bioguideId>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <firstName>Richard</firstName>
        <lastName>Blumenthal</lastName>
        <party>D</party>
        <state>CT</state>
        <identifiers>
          <bioguideId>B001277</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>K000367</bioguideId>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <firstName>Amy</firstName>
        <lastName>Klobuchar</lastName>
        <party>D</party>
        <state>MN</state>
        <identifiers>
          <bioguideId>K000367</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001176</bioguideId>
        <fullName>Sen. Merkley, Jeff [D-OR]</fullName>
        <firstName>Jeff</firstName>
        <lastName>Merkley</lastName>
        <party>D</party>
        <state>OR</state>
        <identifiers>
          <bioguideId>M001176</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000122</bioguideId>
        <fullName>Sen. Reed, Jack [D-RI]</fullName>
        <firstName>John</firstName>
        <lastName>Reed</lastName>
        <party>D</party>
        <state>RI</state>
        <identifiers>
          <bioguideId>R000122</bioguideId>
        </identifiers>
        <middleName>F.</middleName>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001230</bioguideId>
        <fullName>Sen. Baldwin, Tammy [D-WI]</fullName>
        <firstName>Tammy</firstName>
        <lastName>Baldwin</lastName>
        <party>D</party>
        <state>WI</state>
        <identifiers>
          <bioguideId>B001230</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001076</bioguideId>
        <fullName>Sen. Hassan, Margaret Wood [D-NH]</fullName>
        <firstName>Maggie</firstName>
        <lastName>Hassan</lastName>
        <party>D</party>
        <state>NH</state>
        <identifiers>
          <bioguideId>H001076</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001288</bioguideId>
        <fullName>Sen. Booker, Cory A. [D-NJ]</fullName>
        <firstName>Cory</firstName>
        <lastName>Booker</lastName>
        <party>D</party>
        <state>NJ</state>
        <identifiers>
          <bioguideId>B001288</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000033</bioguideId>
        <fullName>Sen. Sanders, Bernard [I-VT]</fullName>
        <firstName>Bernard</firstName>
        <lastName>Sanders</lastName>
        <party>I</party>
        <state>VT</state>
        <identifiers>
          <bioguideId>S000033</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000944</bioguideId>
        <fullName>Sen. Brown, Sherrod [D-OH]</fullName>
        <firstName>Sherrod</firstName>
        <lastName>Brown</lastName>
        <party>D</party>
        <state>OH</state>
        <identifiers>
          <bioguideId>B000944</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000555</bioguideId>
        <fullName>Sen. Gillibrand, Kirsten E. [D-NY]</fullName>
        <firstName>Kirsten</firstName>
        <lastName>Gillibrand</lastName>
        <party>D</party>
        <state>NY</state>
        <identifiers>
          <bioguideId>G000555</bioguideId>
        </identifiers>
        <middleName>E.</middleName>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000802</bioguideId>
        <fullName>Sen. Whitehouse, Sheldon [D-RI]</fullName>
        <firstName>Sheldon</firstName>
        <lastName>Whitehouse</lastName>
        <party>D</party>
        <state>RI</state>
        <identifiers>
          <bioguideId>W000802</bioguideId>
        </identifiers>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <identifiers>
          <bioguideId>D000563</bioguideId>
        </identifiers>
        <middleName>J.</middleName>
        <sponsorshipDate>2021-05-27</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Canada</name>
        </item>
        <item>
          <name>Civil actions and liability</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Digestive and metabolic diseases</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Executive agency funding and structure</name>
        </item>
        <item>
          <name>Government information and archives</name>
        </item>
        <item>
          <name>Government studies and investigations</name>
        </item>
        <item>
          <name>Health care costs and insurance</name>
        </item>
        <item>
          <name>Infectious and parasitic diseases</name>
        </item>
        <item>
          <name>Inflation and prices</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Marketing and advertising</name>
        </item>
        <item>
          <name>Medicaid</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medicare</name>
        </item>
        <item>
          <name>National Institutes of Health (NIH)</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Public contracts and procurement</name>
        </item>
        <item>
          <name>Retail and wholesale trades</name>
        </item>
        <item>
          <name>Sales and excise taxes</name>
        </item>
        <item>
          <name>Trade restrictions</name>
        </item>
        <item>
          <name>User charges and fees</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2021-05-27</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2021-08-05T21:58:09Z</updateDate>
        <text>
          <![CDATA[ <p><b>Affordable Medications Act</b></p> <p>This bill revises and expands various requirements relating to prescription drug pricing and affordability.&nbsp;</p> <p>Specifically, the bill expands financial reporting requirements for drug manufacturers&nbsp;and establishes corresponding civil penalties for noncompliance; it also adds reporting requirements for certain nonprofit patient-assistance programs.</p> <p>Further, the bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to negotiate prices for certain prescription drugs under Medicare and requires the Centers for Medicare and Medicaid Innovation within the CMS to test specified models for negotiating drug prices. It also establishes reporting requirements, and corresponding civil penalties for noncompliance,&nbsp;for pharmaceutical companies with respect to spikes in prescription drug prices. </p> <p>The bill establishes an excise tax on prescription drugs subject to price spikes, lessens prescription drug cost-sharing requirements under qualified health plans and group health plans, and modifies requirements for the importation of prescription drugs.</p> <p>It also requires drug manufacturers to provide rebates for drugs dispensed to certain low-income individuals under the Medicare program and limits the time frame that trade agreements are required to provide market exclusivity for biological products.</p> <p>Additionally, the bill (1) requires the Food and Drug Administration to establish a database of generic drugs; (2) modifies other provisions related to generic drugs, prescription drug advertising, disclosure of wholesale acquisition prices, and patent-infringement proceedings; and (3) revises certain time frames and conditions related to drug exclusivity.</p> <p>Finally, it establishes an innovation incentive fund for new or more effective treatments of bacterial infections and establishes the Center for Clinical Research within the National Institutes of Health.</p>]]>
        </text>
      </summary>
    </summaries>
    <title>Affordable Medications Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Affordable Medications Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to ensure medications are affordable.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Affordable Medications Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2021-05-27T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117s1898is/xml/BILLS-117s1898is.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date/>
        <formats/>
        <type/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2021-05-27</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
